Analysts Have Conflicting Sentiments on These Technology Companies: Endava (DAVA), Genpact (G) and Oracle (ORCL)
Companies in the Technology sector have received a lot of coverage today as analysts weigh in on Endava (DAVA – Research Report), Genpact (G – Research Report) and Oracle (ORCL – Research Report).
Valentine's Day Sale - 70% Off
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Endava (DAVA)
In a report released today, James Faucette from Morgan Stanley maintained a Hold rating on Endava, with a price target of $8.00. The company’s shares closed last Friday at $5.46.
According to TipRanks.com, Faucette is a 4-star analyst with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Endava with a $10.00 average price target, implying a 95.7% upside from current levels. In a report issued on January 26, TipRanks – OpenAI also reiterated a Hold rating on the stock with a $7.50 price target.
See the top stocks recommended by analysts >>
Genpact (G)
In a report released today, Sean Kennedy from Mizuho Securities reiterated a Hold rating on Genpact, with a price target of $49.00. The company’s shares closed last Friday at $40.39.
According to TipRanks.com, Kennedy is ranked 0 out of 5 stars with an average return of
Currently, the analyst consensus on Genpact is a Moderate Buy with an average price target of $49.00, a 25.7% upside from current levels. In a report issued on February 4, TipRanks – DeepSeek also downgraded the stock to Hold with a $43.00 price target.
Oracle (ORCL)
In a report released today, Gil Luria from D.A. Davidson maintained a Buy rating on Oracle, with a price target of $180.00. The company’s shares closed last Friday at $142.82.
According to TipRanks.com, Luria is a 4-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Oracle with a $294.25 average price target, representing an 110.6% upside. In a report issued on February 1, Guggenheim also maintained a Buy rating on the stock with a $400.00 price target.
